CXCL8 may serve as a potential biomarker for predicting the prognosis and immune response in cervical cancer
Abstract Objective: To investigate the prognostic significance of CXCL8 in cervical cancer and its effect on immune response based on bioinformatics method. Methods: This study employs the HPA database to investigate CXCL8 expression in normal human tissues.The TIMER2.0 database is utilized to analyze CXCL8 expression across various types of cancer.Utilizing the TCGA database, we analyze the correlation between CXCL8 and the overall survival (OS) and progression-free interval (PFI) of patients with various tumors using R 4.3.2.Additionally, its association with immune
This article is available to registered members
Create a free account to access our full library of peer-reviewed research on medical cannabis.
Join — it's freeAlready a member? Log in
